H.R.3493

Global Fairness in Drug Pricing Act aims to align U.S. drug prices with international benchmarks.

The Global Fairness in Drug Pricing Act seeks to reduce prescription drug prices by aligning U.S. prices with international benchmarks. It mandates the Secretary of Health and Human Services to propose a rulemaking plan for most-favored-nation price targets. The Act also requires the Secretary to facilitate direct-to-consumer purchasing programs and certify that importing drugs from developed countries poses no health risk and significantly reduces costs. Additionally, it directs the Secretary of Commerce and the U.S.